Skip to content
OpenCapital
Get started

Halozyme Therapeutics HALO Shares (Diluted)

Shares (Diluted) at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
72.4M-0.8%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
194.8M+2.4%
Arrowhead Research logo
Arrowhead ResearchARWR
142.4M+5.9%
AbbVie logo
AbbVieABBV
1.8B+0.1%
Alkermes logo
AlkermesALKS
166.2M-1.5%
AptarGroup logo
AptarGroupATR
——

Other financials

Income statement

See full
Revenue$376.7M+42.2%
Gross profit$297.5M+37.4%
Operating income$184.5M+30.4%
Net income$150.0M+27.1%
EPS (diluted)$1.22+31.2%

Balance sheet

See full
Cash & equivalents$312.0M+76.9%
Total debt$2.2B+41.7%
Total equity$219.6M-54.5%
Total assets$2.7B+21.7%

Cash flow

See full
Operating cash flow$180.1M+16.8%
CapEx$3.7M+294%
Free cash flow$176.3M+15.0%

Valuation

See full
Market cap$8.13B-2.9%
Enterprise value$10B+3.0%
P/E13.4×-3.8×
P/S5.4×-2.3×

Profitability

See full
Gross margin82.8%-0.7pp
Operating margin59.3%+9.0pp
Net margin47.9%+6.5pp
FCF margin44.3%-1.5pp

Returns & leverage

See full
Return on equity124.5%+12.7pp
Debt / equity9.9×+6.7×
Current ratio2.8×-5.6×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Halozyme Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Halozyme Therapeutics's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Halozyme Therapeutics's shares (diluted)?
Halozyme Therapeutics (HALO) reported shares (diluted) of 122.9M in Q1 2026.
How has Halozyme Therapeutics's shares (diluted) changed year-over-year?
Halozyme Therapeutics's shares (diluted) decreased by 3.0% year-over-year, from 126.6M to 122.9M.
What is the long-term trend for Halozyme Therapeutics's shares (diluted)?
Over 4 years (2021 to 2025), Halozyme Therapeutics's shares (diluted) has grown at a -4.2% compound annual growth rate (CAGR), from 589.7M to 497M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.